JAC Advance Access originally published online on June 24, 2008
Journal of Antimicrobial Chemotherapy 2008 62(2):217-218; doi:10.1093/jac/dkn258
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorial |
Randomized controlled trials in the Journal of Antimicrobial Chemotherapy
1 Department of Medicine E, Rabin Medical Center, Beilinson Campus, 49100 Petah-Tiqva, Israel 2 Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel Aviv, Israel 3 JAC Editorial Office, Griffin House, 53 Regent Place, Birmingham B1 3NJ, UK
* Corresponding author. Tel: +972-3937-6501; Fax: +972-3937-6512; E-mail: leibovic{at}post.tau.ac.il
Abstract
The Journal of Antimicrobial Chemotherapy welcomes submissions of well-reported randomized controlled trials (RCTs) with solid methodology based on the CONSORT statement (http://www.consort-statement.org). The Journal would be especially happy to publish RCTs in the area of antimicrobial chemotherapy if they address significant problems and look at measurable outcomes that matter to patients.
Keywords: evidence-based medicine , clinical outcomes